iSpecimen Inc.
ISPC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | -$0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -6.4% | -4.6% | -6.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 42.9% | 51.4% | 54.3% | 52.9% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -137% | -88.7% | -84.6% | -52.6% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -134.5% | -111.8% | -98.5% | -80.5% |
| EPS Diluted | -17.58 | -24.55 | -20.44 | -24.51 |
| % Growth | 28.4% | -20.1% | 16.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |